Appointments

Request an Appointment

Cancer Answer Line:
866.223.8100

M-F 8 a.m. - 4:30 p.m. ET

Expand Content

Cancer Clinical Trials Results

IRBCCTitleHospitalStagePhaseDisease
2559  Genetic and molecular analysis of tumors of the Nervous system and their coverings Main Campus  Brain
ABTC 120213-927 Phase I Study of MK-1775 with Radiation and Temozolomide in Patients with Newly Diagnosed Glioblastoma and Evaluation of Intratumoral Drug Distribution in Patients with Recurrent Glioblastoma Main Campus Phase 1Brain, Glioblastoma
ABTC 1301 14-1212 Pilot Study of MLN0128 in Preoperative Recurrent Glioblastoma (GBM) Patients Main Campus  Brain, Glioblastoma, Gliosarcoma
ANG 111414-1095 A Phase II, Open-Label, Multi-Center Study of ANG1005 in Breast Cancer Patients with Recurrent Brain Metastases Main Campus Phase 2Brain, Breast
BTTC 331213-042 A Phase I-II Trial of Everolimus and Sorafenib in Patients with Recurrent High Grade Gliomas Main Campus  Brain
CASE 1307296 Ohio Brain Tumor Study (OBTS) Main Campus  Brain
CASE 331313-445 A prospective phase II trial of NovoTTF-100A with Bevacizumab (Avastin) in Patients with Recurrent Glioblastoma Main Campus Phase 2Brain, Glioblastoma
CASE 4309CC845 Phase I/II Trial of Radiosurgery Plus Bevacizumab in Patients with Recurrent / Progressive Glioblastoma Main Campus Phase 1, Phase 2Brain
CASE 441313-1081 Phase II study of Radioimmunotherapy with Zevalin (Ibritumomab Tiuxetan) Therapy for Patients with Refractory or Relapsed Primary Central Nervous System Lymphoma (PCNSL) Main Campus Phase 2Brain, Lymphoma, PCNSL (Primary Central Nervous System Lymphoma)
CASE 731213-143 Neoadjuvant Radiosurgery for resectable brain metastases: Phase I/II Study Main Campus Phase 1, Phase 2Brain
CASE 831213-221 Dose Escalation for Larger Brain Metastases: Phase I/II Study Main Campus Phase 1, Phase 2Brain
CLTR 1314 14-1483 Phase 2, Open-Label, Imaging Trial of I-124-CLR1404 in Patients with Newly Diagnosed or Recurrent Glioblastoma Main Campus Phase 2Brain, Glioblastoma
DFCI 231212-940 An open-label, Phase II Trial of Orally Administered PF-00299804 in Adult Patients with Relapsed/Recurrent Glioblastoma (GBM) Main Campus Phase 2Brain, Glioblastoma
INFT 1314 14-831 A Pilot Trial of Intraparenchymally-Administered Topotecan using Convection-Enhanced Delivery (CED) in Patients with Suspected Recurrent/Progressive WHO Grade III or IV (High Grade) Glioma Requiring Stereotactic Biopsy (IND 117,240) Main CampusStage 3, Stage 4 Brain, Glioblastoma
INFT 1315 15-614 A Pilot Trial of Intraparenchymally-Administered Topotecan using Convection-Enhanced Delivery (CED) in Patients with Suspected Recurrent/Progressive WHO Grade III or IV (High Grade) Glioma Undergoing A Clinically-Indicated Surgical Resection (IND 117,240) Main Campus  Brain, Glioma
MONT 131112-007 LAASR: Laser Ablation After Stereotactic Radiosurgery Main Campus  Brain
NCCTG107C12-123 N107C A Phase III Trial of Post-Surgical Stereotactic Radiosurgery (SRS) compared with whole brain radiotherapy (WBRT) for resected metastatic brain disease Main Campus Phase 3Brain
RTOG 0834CC945 Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial. Main Campus Phase 3Brain
RTOG 111412-583 A Phase II Randomized Study of Rituximab, Methotrexate, Vincristine and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma Main Campus Phase 2Brain
RTOG 111913-551 Phase II Randomized study of whole brain radiotherapy in combination with concurrent lapatinib in patients with brain metastasis from HER2-Positive Breast cancer. A collaborative study of RTOG and KROG. Beachwood, Fairview, Hillcrest, Independence, Mansfield, North Coast Cancer, Parma, Strongsville, Wooster Phase 2Brain, Breast
12

Cancer Answers & Appointments

Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.

Monday through Friday from 8 a.m. – 4:30 p.m. (ET).

Referrals

Resources for medical professionals

  • Outpatient appointment referrals: 216.444.7923 or 866.223.8100
  • Inpatient hospital transfers: 800.553.5056
  • Referring Physician Concierge: 216.444.6196 or 216.312.4910.

Clinical Trials

Search available cancer clinical trials by disease, hospital, phase or number.

This information is provided by Cleveland Clinic and is not intended to replace the medical advice of your doctor or health care provider. Please consult your health care provider for advice about a specific medical condition.

© Copyright 2015 Cleveland Clinic. All rights reserved.